Anna Kron

7PUBLICATIONS
75CO-AUTHORS
Molecular targetsPredictive and prognostic markersMedical bacteriologyCardiology (incl. cardiovascular diseases)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Oct 08, 2026
FIND: a phase-II study to evaluate the efficacy and safety of erdafitinib in FGFR-altered NSCLC.

|Jun 10, 2026
Molecular and clinical characteristics of patients with non-small cell lung cancer (NSCLC) harboring KRAS Q61 mutations to assess therapeutic responses.

|May 28, 2026
Implementation of patient-reported outcomes in personalized lung cancer care: a qualitative study from the perspective of patients and health care providers.

|Dec 19, 2025
Molecular and Clinical Characteristics of Patients with Non-Small Cell Lung Cancer Harboring KRAS G12V Mutations.

Felix John, Lea Ruge, Malte Verheyen

|Jan 21, 2023
Health economic analysis of patients treated with isavuconazole in a German comprehensive cancer centre.

Julia Jeck, Sebastian M Wingen-Heimann, Florian Jakobs

|Jan 18, 2023
An Adjusted Treatment Comparison Comparing Amivantamab Versus Real-World Clinical Practice in Europe and the United States for Patients with Advanced Non-Small Cell Lung Cancer with Activating Epidermal Growth Factor Receptor Exon 20 Insertion Mutations.

Christos Chouaid, Lise Bosquet, Nicolas Girard

Pageof 2

Frequent Collaborators

4 joint publications

Matthias Scheffler

4 joint publications

Anna Rasokat

3 joint publications

Florian Kron

3 joint publications

Heather Scharpenseel